|
|
| Research article summary (published 27 Feb 1994): |
Regional cerebral blood flow in IDDM patients: effects of diabetes and of recurrent severe hypoglycaemia.
Full Abstract
Chronic hyperglycaemia and recurrent severe hypoglycaemia have both been implicated as causing cerebral damage in patients with diabetes. Although cognitive dysfunction and intellectual impairment have been demonstrated in patients with recurrent severe hypoglycaemia, structural correlates have not been described, and it is not known whether specific functional changes occur in the brains of affected patients. Regional cerebral blood flow was estimated by SPECT with 99mTechnetium Exametazime in 20 patients with IDDM. Ten patients had never experienced severe hypoglycaemia and 10 had a history of recurrent severe hypoglycaemia. Patient results were compared with 20 age- and sex-matched healthy volunteers. We observed differences between the two patient groups and the control group. Tracer uptake was greater in diabetic patients in the superior pre-frontal cortex. This effect was particularly pronounced in the group who had a history of previous severe hypoglycaemia. Patients with a history of recurrent hypoglycaemia also had a relative reduction in tracer uptake to the calcarine cortex. This suggests an alteration in the pattern of baseline regional cerebral blood flow in diabetic patients with frontal excess and relative posterior reduction in cerebral blood flow.
Author information
Author/s: MacLeod, K M (KM); Hepburn, D A (DA); Deary, I J (IJ); Goodwin, G M (GM); Dougall, N (N); Ebmeier, K P (KP); Frier, B M (BM);
Affiliation: Department of Diabetes, Royal Infirmary, Edinburgh, Scotland.
Grants: (Agency:Wellcome Trust)
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal: Diabetologia (Diabetologia), published in GERMANY. (Language: eng)
Reference: 1994-Mar; vol 37 (issue 3) : pp 257-63
Dates: Created 1994/06/08; Completed 1994/06/08; Revised 2009/09/29;
PMID: 8174839, status: MEDLINE (last retrieved date: 9/29/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Organotechnetium Compounds (0) ; Oximes (0) ; Technetium Tc 99m Exametazime (100504-35-6)Related articles
These are the most related articles currently in our database:
- Perfusion mapping with Tc-HMPAO in cerebral haematomas.
29 Nov 1991 - Validation to eliminate vascular activity on 99Tcm-HMPAO brain SPECT for regional cerebral blood flow (rCBF) determination.
30 May 1991 - Clinical SPRINT imaging. Preliminary results compared to conventional SPECT brain scanning using Tc-99m HMPAO.
30 Jul 1991 - Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer disease.
21 Jun 1990 - Visual stimulation increases technetium-99m-HMPAO distribution in human visual cortex.
30 Jan 1991 - Kinetic behavior of technetium-99m-HMPAO in the human brain and quantification of cerebral blood flow using dynamic SPECT.
30 Dec 1991 - MR imaging and HMPAO scintigraphy in conjunction with balloon test occlusion: value in predicting sequelae after permanent carotid occlusion.
30 Oct 1992 - [Quantification of regional cerebral blood flow using 99mTc-HMPAO SPECT and intravenous 133Xe injection method]
29 Nov 1992 - Cognition and 99Tcm-HMPAO SPECT in Parkinson's disease.
29 Sep 1992 - Technetium-99m-d,1-hexamethylpropyleneamine oxime (HMPAO) uptake and glutathione content in brain tumors.
30 Aug 1991
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.